Andrew Gardiner

Syntropharma Ltd. produces and distributes pharmaceutical products. It specializes in the development of the skin patches of proven medicines targeting diseases affecting the central nervous system. The company was founded by Andrew Gardiner and David McHoul on February 1, 2005 and is headquartered in Newtown St Boswells, the United Kingdom.

Libero Pharma Ltd. is a British company that aims to improve addiction management by mitigating the issues associated with existing formulations of naltrexone. The company is based in Edinburgh, UK. Naltrexone is a prescription medicine used for addiction management in the USA, which works by blocking the effects of drugs known as opiates. However, its utility is limited by the current delivery methods, which include oral and intramuscular injection. Libero Pharma was founded by Andrew Gardiner, who has been the CEO since incorporation.

Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom.

Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.